IRadimed Corporation IRMD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.98M | 23.06M | 23.61M | 22.48M | 21.18M |
| Total Depreciation and Amortization | 1.66M | 1.63M | 1.43M | 1.17M | 980.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.06M | 5.11M | 5.35M | 5.65M | 3.03M |
| Change in Net Operating Assets | -3.55M | -2.65M | -1.44M | -4.34M | -183.90K |
| Cash from Operations | 27.15M | 27.14M | 28.95M | 24.95M | 25.01M |
| Capital Expenditure | -1.01M | -2.02M | -4.47M | -7.77M | -10.26M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -528.20K | -572.20K | -502.20K | -656.20K | -800.80K |
| Cash from Investing | -1.54M | -2.59M | -4.97M | -8.42M | -11.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 25.70K |
| Repurchase of Common Stock | -2.62M | -2.63M | -2.50M | -2.56M | -784.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -16.23M | -15.83M | -15.43M | -15.04M | -8.39M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.85M | -18.46M | -17.93M | -17.60M | -9.15M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | 1.00K | 0.00 | 0.00 | 1.00K |
| Net Change in Cash | 6.76M | 6.08M | 6.04M | -1.08M | 4.81M |